Literature DB >> 33623419

Evaluation of the Effect of Patient Preparation Using Castor Oil on ADC Value of Focal Liver Lesion.

Kawa Abdulla Mahmood1, Rezheen Jamal Rashid1, Salah Mohammed Fateh1, Naser Abdullah Mohammed1.   

Abstract

PURPOSE: To estimate the role of patient preparation using castor oil on the ADC value of focal liver lesion. PATIENTS AND METHODS: Retrospective case-control study over more than two years. Magnetic resonance imaging (MRI) scan, including diffusion-weighted imaging (DWI) of the upper abdomen performed for 87 cases and 71 controls in patients with focal hepatic hemangiomas. Cases were prepared using castor oil prior to the scan without identifiable unwanted effect, while controls did not receive any special preparation. Since liver hemangioma is a common lesion, it was selected and used as a sample. Apparent Diffusion Coefficient (ADC) values of focal liver lesion were calculated in cases and controls.
RESULTS: The mean ADC value of liver hemangioma was lower in cases compared to controls; the mean ADC value was (2.21±0.39x10-3mm2/s) in cases and (2.51±0.49x10-3mm2/s) in controls. Left lobes were more affected by lesions; the mean ADC value of the left lobe lesions was (2.26±0.37 x10-3mm2/s) and (2.86±0.43 x10-3mm2/s) in cases and controls, respectively. The ADC value of lesions in the right lobe was (2.19±0.39x10-3mm2/s) in cases and (2.39± 0.45x10-3mm2/s) in controls. There was a significant segmental ADC variation; lesions at segments II, III, IVb, and V demonstrated illusive ADC elevation in controls.
CONCLUSION: There is erroneous elevation of lobar and segmental ADC value of liver hemangiomas in non prepared patients. This Potential source of error (peristalsis, partial volume, and paramagnetic gas effect of gastrointestinal tract) on hepatic lesions' ADC value can be avoided by proper preparation using castor oil prior to MRI scanning.
© 2021 Mahmood et al.

Entities:  

Keywords:  apparent diffusion coefficient value; castor oil; liver hemangioma; patient preparation

Year:  2021        PMID: 33623419      PMCID: PMC7896795          DOI: 10.2147/IJGM.S289661

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


Introduction

Since its introduction, MRI has been an attractive imaging modality for different body parts due to its detailed functional information and lack of ionizing radiation, particularly for liver imaging. Based on the Brownian motion of water molecules due to thermal agitation, diffusion is a reliable imaging method for tissue characterization. Performing diffusion-weighted imaging (DWI) on liver examination allows quantitative characterization of liver lesions. The MR software automatically produces an apparent diffusion coefficient (ADC) Map.1–7 Nowadays, MRI is the modality of choice for liver lesions detection and characterization, and the DWI sequence is used as a biomarker due to its role at the molecular level. The diagnostic confusion among various liver lesions can be reduced using ADC value measuring that may add information about the pathological process.8–12 Several factors affects on ADC value variability as vendor characteristics, magnetic field strength, different diffusion-weighted images protocol, different b values, software platform, gastrointestinal intraluminal content and peristalsis, liver steatosis, liver parenchymal disease, metabolic liver disease, lesion size and location, intra-lesional complication as hemorrhage, inflammation or thrombosis, and age-related variation.1,2,4,5,13–23 Among the hepatic lesions, hemangioma is the most common lesion in about 20% of the general population, and its atypical presentation is not uncommon. MRI is regarded as a reliable tool for diagnosis with a high accuracy rate.10,24 Oral administration of castor oil before the MRI scan has to affect empty the stomach and bowel due to its laxative effect and improving image quality. Bowel preparation is regarded as necessary prior to radiological examinations of the abdominal region.25–28 Oral intake of castor oil might induce nausea; otherwise, it is generally recognized and classified as safe and effective for use as a stimulant laxative.29,30

Objective

This study aims to estimate the role of patient preparation using castor oil on the ADC value of focal liver lesion.

Patients and Methods

MRI scan of the upper abdomen was carried out for 158 patients with age 18–60 years from May 2018 till July 2020 at Hiwa Cancer Hospital. This study was conducted in accordance with the Declaration of Helsinki. Formal ethical approval was obtained from the local ethical committee –University of Sulaimani/College of Medicine, after hospital authentication informed consents were obtained from all patients. Only patients with particular liver lesions were included: Patients with typical hemangioma that fulfills radiological criteria (hypointense on T1-weighted images, homogenous and hyperintense on T2-weighted images “similar to cerebrospinal fluid”, absence of restriction on DWI, and slow enhancement kinetics, in the form of peripheral nodular enhancement, progressive, centripetal, late, full and persistent filling).19,24,31 Only hemangiomas ranging from 10 to 50 mm were included. Our sample size was 220 patients. We excluded those with atypical hemangioma, parenchymal liver disease, ages below 18 and above 60 years, and patients who received chemotherapy. The number of included patients was 158 patients, while 62 patients were excluded among the cases and controls. We retrospectively categorized the patients into two groups; group one (cases or prepared patients) and group two (controls or non-prepared patients). Group one consisted of 87 prepared patients who received castor oil before the MRI study and group two (71 non-prepared patients) who refused to receive the castor oil. The cases were prepared by drinking 50mL of castor oil (Oleum Palmae Christi) on the day before the exam to purge the bowel and reduce the motion artifact from distorting paramagnetic gas and partial volume of gastrointestinal content on focal liver lesions’ ADC value. In contrast, the control group did not receive any special preparation. No identifiable unwanted effect were recorded. Patients underwent an MRI scan of the upper abdomen for different purposes. Patients were scanned using the same MRI scanner (MAGNETOM Aera 1.5Tesla) and the same MRI protocol. Cardiac and respiratory-triggered axial DWI (b=50 and b=800 s/mm2) was obtained. ADC map was generated by the MR scanner using the b values systematically. In addition to the DWI, other sequences were obtained as part of MRI scanning, as shown in Table 1.
Table 1

MRI Sequences

MRI Sequences and Parameters
Axial T2 haste fat suppression(TR/TE:1000/93ms)
Coronal and axial T2 haste(TR/TE: 1000/89ms)
Axial dual opposed-phase T1WI vibe Dixon(in phase TR/TE:6.8/4.8, out phase TR/TE: 6.8/2.4ms)
Axial and coronal pre-contrast T1WI vibe Dixon(TR/TE: 6.8/4.8ms)
Axial pre and post contrast T1fat suppression vibe(TR/TE: 4.8/2.3ms)
MRI Sequences A round region of interest (ROI) was manually drawn, covering most of the lesion. Dedicated workstation (Hp server-based workstation, syngo.via Version: VB10B) used for ADC analysis. Three expert radiologists who were blinded to the bowel preparation plan (with 18, 13, and 9 years of experience in abdominal imaging) reviewed the ADC map. The statistical analysis was performed using SPSS version 21.0 (Student’s t-test was used to calculate the mean values, and 0.05 was considered as cut-off point for statistical significance). The data supporting this study is uploaded in the form of Excel sheet file which contains data about age and gender of the patients, also number and size of the lesions, as well as ADC value of hemangioma in both cases and controls at different liver segments.

Results

A total of 158 patients with 235 liver hemangiomas (87 cases with 123 liver lesions and 71 controls with 112 liver lesions) included, the age ranges from 18 to 60 years (mean age 41.1±11.8), and (female to male ratio 2.2:1). Multiple hemangiomas were present in 41 patients, 18 patients (11.3%) had two hemangiomas, 3 lesions, 4 lesions, 5 lesions found in 13 (8.2%), 7 (4.5%), and 3 (1.8%) patients, respectively, 173 (73.6%) lesions were in Rt. Lobe and 62 (26.4%) lesions in the left lobe. The mean ADC value of liver hemangioma was lower in cases versus control patients. The mean ADC value of liver hemangioma at both lobes was affected by preparation to a variable degree, as shown in Table 2.
Table 2

ADC Value of the Left Lobe Compared to the Right Lobe Hemangiomas

Mean ADC Value of Hemangioma (×10ˉ3mm2/s)P value
CaseControl
Liver lesion2.21 ± 0.392.51 ± 0.49< 0.0001
Right lobe lesion2.19 ± 0.392.39 ± 0.450.0021
Left Lobe lesion2.26 ± 0.372.86 ± 0.43< 0.0001
ADC Value of the Left Lobe Compared to the Right Lobe Hemangiomas There was a segmental hemangioma ADC variation of prepared versus non-prepared subjects; lesions at segments II, III, IVb, and V were significantly affected by GIT content, as summarized in Table 3.
Table 3

The Number and the Mean ADC Values of Hemangiomas in Cases and Controls at Different Hepatic Segments

Liver SegmentsCasesControlsP-value
No. of HemangiomaMean ADC Value (×103mm2/s)No. of HemangiomaMean ADC Value (×103mm2/s)
Segment I011.98
Segment II162.42 ± 0.27132.91 ± 0.50.0023
Segment III192.13 ± 0.4142.82 ± 0.340.0002
Segment IVa182.24 ± 0.38162.4 ± 2.430.2578
Segment IVb112.18 ± 0.37112.65 ± 0.490.0195
Segment V122.04 ± 0.36152.43 ± 0.390.0131
Segment VI132.27 ± 0.35112.51 ± 0.50.1817
Segment VII192.22 ± 0.4142.39 ± 0.330.2043
Segment VIII152.16 ± 0.42172.14 ± 0.40.8913
The Number and the Mean ADC Values of Hemangiomas in Cases and Controls at Different Hepatic Segments

Discussion

Different liver lesions showed variable ADC values.4,5 In our analysis, we selected and used liver hemangioma as a sample to assess the effect of patient preparation on ADC value since hemangioma is a common lesion (up to 20% of the general population), and it tends to subcapsular and peripheral location.10,31,32 Focal liver lesion ADC value is influenced by many factors as hardware and software variability, diffusion protocol, gastrointestinal content and peristalsis, chemotherapy drugs, fatty liver disease, liver parenchymal disease, metabolic liver disease, lesion size and location, intra-lesional complication as hemorrhage, inflammation or thrombosis, age-related variation.1,2,4,5,13–23 After controlling the mentioned factors’ effects via scanning all patients with the same MR scanner and using the same MR imaging protocol, excluding patients on chemotherapy, diffuse liver disease, lesion complication, and eliminating aging factor, we observed the impact of gastrointestinal content solely on ADC variance of liver hemangioma (Table 2). Typically, liver hemangioma appeared hyper intense on T2WI (Figure 1A) and not restricted on DWI2 (as shown in Figure 1B–D). The mean ADC values were lower in cases (Figure 1A–D) compared to controls. This significant false ADC value elevation (p-value < 0.0001) in controls is related to GIT content and its associated partial volume effect from bowel peristalsis.
Figure 1

MRI scan displaying segment II subcapsular typical liver hemangioma in a 48-years old case (prepared with castor oil). (A) The lesion is hyperintense on T2WI. (B) The hemangioma is hyperintense at b value 50 mm2/s, whereas (C) moderately hyperintense at b values 800 mm2/s. (D) The quantitative ADC data of the lesion is (2.108 ± 0.13 ×10−3 mm2/s).

MRI scan displaying segment II subcapsular typical liver hemangioma in a 48-years old case (prepared with castor oil). (A) The lesion is hyperintense on T2WI. (B) The hemangioma is hyperintense at b value 50 mm2/s, whereas (C) moderately hyperintense at b values 800 mm2/s. (D) The quantitative ADC data of the lesion is (2.108 ± 0.13 ×10−3 mm2/s). The mean ADC value of liver hemangioma was significantly different; (2.21±0.39 x 10ˉ3mm2/s) in cases while (2.51 ± 0.49 x10ˉ3mm2/s) in controls. There is also lobar ADC variation; left lobe lesions were more affected by the GIT content, mean ADC value was (2.26±0.37 x10ˉ3mm2/s) in cases and (2.86±0.43 x10ˉ3mm2/s) in control subjects compared to Right lobe lesions (2.19±0.39 x10ˉ3mm2/s) and (2.39±0.45 x10ˉ3mm2/s) in cases and controls, respectively. In our dataset, illusive ADC value elevation of liver lesions in controls (Figure 2A–D) denoted that GIT content negatively affected on ADC value of liver lesions. This concept was advocated by previous authors who referred that left lobe lesions showed deceptively elevated ADC value due to peristalsis, distorting gas, and partial volume effects of adjacent organs.6,18,23,33 Up to our knowledge, no previous study documented the difference quantitatively.
Figure 2

MRI is demonstrating segment II typical liver hemangioma in a 43-years non-prepared patient. (A) The hemangioma is homogenously hyperintense on T2WI. (B and C) The lesion is demonstrating variable high signal intensity on DWI at b values 50 and 800 mm2/s, respectively. (D) On the ADC map, the lesion’s ADC value is (2.397±0.48 ×10−3 mm2/s).

MRI is demonstrating segment II typical liver hemangioma in a 43-years non-prepared patient. (A) The hemangioma is homogenously hyperintense on T2WI. (B and C) The lesion is demonstrating variable high signal intensity on DWI at b values 50 and 800 mm2/s, respectively. (D) On the ADC map, the lesion’s ADC value is (2.397±0.48 ×10−3 mm2/s). In addition to lobar ADC differences, we calculated the hepatic segmental ADC value mismatches in both groups (Table 3). Moreover, ADC values among the controls were significantly higher at segments II (Figure 1A and Figure 2D), III, IVb, and V than in the cases, which can be explained by their proximity to the gastrointestinal tract. Comparison of ADC value of lesions at segment I was not possible since we had a single hemangioma in group two. Unlike respiration and cardiac pulsation, which notably affect the left lobe ADC scales,6,18,19,23,34 gastric and bowel content also affects right lobe lesions, we came to the conclusion that good preparation reduced evitable potential source of error in ADC measurement of liver lesions from gastric and bowel content even if located at liver periphery near the GIT content.

Conclusion

There is erroneous elevation of lobar and segmental ADC value of liver lesions in non prepared patients. This Potential source of error (peristalsis, partial volume, and paramagnetic gas effect of gastrointestinal content) on hepatic lesions’ ADC value can be diminished by proper preparation using castor oil prior to MRI scanning.
  32 in total

1.  Characterization of Liver Tumors by Diffusion-Weighted Imaging: Comparison of Diagnostic Performance Using the Mean and Minimum Apparent Diffusion Coefficient.

Authors:  Tomohiro Namimoto; Masataka Nakagawa; Yuuki Kizaki; Ryo Itatani; Masafumi Kidoh; Daisuke Utsunomiya; Seitaro Oda; Yasuyuki Yamashita
Journal:  J Comput Assist Tomogr       Date:  2015 Jul-Aug       Impact factor: 1.826

Review 2.  Diffusion-weighted MR imaging of the liver.

Authors:  Bachir Taouli; Dow-Mu Koh
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

3.  Is DWI/ADC a useful tool in the characterization of focal hepatic lesions suspected of malignancy?

Authors:  Maria Luiza Testa; Rubens Chojniak; Letícia Silva Sene; Aline Santos Damascena; Marcos Duarte Guimarães; Janio Szklaruk; Edson Marchiori
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

4.  Variability in quantitative diffusion-weighted MR imaging (DWI) across different scanners and imaging sites: is there a potential consensus that can help reducing the limits of expected bias?

Authors:  Frederic Carsten Schmeel
Journal:  Eur Radiol       Date:  2018-11-28       Impact factor: 5.315

Review 5.  Hepatic haemangioma: common and uncommon imaging features.

Authors:  T Klotz; P-F Montoriol; D Da Ines; V Petitcolin; J Joubert-Zakeyh; J-M Garcier
Journal:  Diagn Interv Imaging       Date:  2013-06-21       Impact factor: 4.026

6.  Imaging of atypical hemangiomas of the liver with pathologic correlation.

Authors:  V Vilgrain; L Boulos; M P Vullierme; A Denys; B Terris; Y Menu
Journal:  Radiographics       Date:  2000 Mar-Apr       Impact factor: 5.333

Review 7.  Diffusion-weighted MRI in the body: applications and challenges in oncology.

Authors:  Dow-Mu Koh; David J Collins
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

8.  Diffusion weighted MR imaging in the differential diagnosis of haemangiomas and metastases of the liver.

Authors:  Nagihan Inan; Furkan Kilinc; Tahsin Sarisoy; Sevtap Gumustas; Gur Akansel; Ali Demirci
Journal:  Radiol Oncol       Date:  2010-03-18       Impact factor: 2.991

9.  Intravoxel Incoherent Motion Diffusion-weighted Imaging: Evaluation of the Differentiation of Solid Hepatic Lesions.

Authors:  Ma Luo; Ling Zhang; Xin-Hua Jiang; Wei-Dong Zhang
Journal:  Transl Oncol       Date:  2017-09-08       Impact factor: 4.243

10.  Evaluation of ADCratio on liver MRI diffusion to discriminate benign versus malignant solid liver lesions.

Authors:  Tarun Pankaj Jain; Wen Ter Kan; Sean Edward; Helen Fernon; Renuvathy Kansan Naider
Journal:  Eur J Radiol Open       Date:  2018-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.